Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Nanosonics Limited ( (AU:NAN) ) is now available.
Nanosonics Limited has announced an update regarding its ongoing share buy-back program. The company reported that it bought back a total of 75,323 ordinary fully paid securities on the previous day, adding to the cumulative total of 74,874 securities bought back prior. This buy-back initiative is part of Nanosonics’ strategy to manage its capital structure effectively, potentially enhancing shareholder value and signaling confidence in the company’s financial health.
The most recent analyst rating on (AU:NAN) stock is a Hold with a A$4.50 price target. To see the full list of analyst forecasts on Nanosonics Limited stock, see the AU:NAN Stock Forecast page.
More about Nanosonics Limited
Nanosonics Limited operates in the healthcare industry, specializing in infection prevention solutions. The company is known for its innovative products that focus on reducing the risk of infection transmission, particularly in medical settings.
YTD Price Performance: 31.89%
Average Trading Volume: 691,017
Technical Sentiment Signal: Sell
Current Market Cap: A$1.21B
Learn more about NAN stock on TipRanks’ Stock Analysis page.